Trimetallic-based nanocarriers method shows promise for visualized idiopathic pulmonary fibrosis therapy

A research group from Ningbo Institute of Materials Technology and Engineering (NIMTE) of the Chinese Academy of Sciences (CAS) developed a novel method for idiopathic pulmonary fibrosis (IPF) therapy by transplanting mesenchymal stem cells (MSCs), which improved the therapeutic efficacy and realized real-time treatment visualization. The study was published in Science Advances.